Status:
COMPLETED
Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Collaborating Sponsors:
Hospital Infantil de Mexico Federico Gomez
Hospital General de México Dr. Eduardo Liceaga
Conditions:
Covid19
Vitamin D
Eligibility:
All Genders
1-17 years
Phase:
PHASE3
Brief Summary
Open controlled clinical trial. Hospitalized pediatric patients with COVID-19 will be included. Upon admission to hospital serum determination of vitamin D, interleukins, ferritin and Dimer D will be ...
Detailed Description
Hospitalized pediatric patients with COVID-19 will be included. The diagnosis of COVID-19 performed through RT-PCR. Upon admission to hospital, a serum determination of Vitamin D, interleukins, ferrit...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Age over 1 month and under 17 years
- Confirmed diagnosis of COVID-19 infection with the results of real-time PCR
- That they agreed to participate in the study.
- That the patient tolerates the enteral route
- Exclusion criteria
- 1\. Have received vitamin D in the four weeks prior to hospitalization.
Exclusion
Key Trial Info
Start Date :
July 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04502667
Start Date
July 15 2020
End Date
September 15 2021
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Centro Medico Nacional Siglo XXI
Mexico City, Mexico City, Mexico, 06720